基于欧洲老年人认知能力下降的综合风险因素的潜在概况:基于SHARE HCAP项目的回顾性研究
Johnnatas Mikael Lopes1,2, Paola Bertuccio1, Riccardo Vecchio1,3
1Department of Public Health, Experimental and Forensic Medicine, University of Pavia, 27100 Pavia, Italy.
Neurology international
|October 28, 2025
概括
这项研究确定了老年人认知能力下降的四个不同的风险概况. "联合集群"的个人资料,包括心理健康不佳和高血压,显示轻度认知障碍 (MCI) 和严重认知障碍 (SCI) 的风险最高.
科学领域:
- 老年学是一门学科.
- 神经科学是一个神经科学.
- 公共卫生 公共卫生
背景情况:
- 认知能力下降是老年人群中普遍存在的问题,有各种可修改的风险因素.
- 现有的研究经常孤立地检查痴呆症风险因素,限制了整体的理解.
- 识别综合风险概况对于有针对性的公共卫生干预至关重要.
研究的目的:
- 根据欧洲老年人痴呆风险因素的组合,确定潜在的个人资料.
- 量化这些已识别的个人资料与认知障碍之间的关联.
- 为预防认知衰退的公共卫生策略提供信息.
主要方法:
- 使用SHARE HCAP项目的数据 (第6波和第9波) 进行了回顾性纵向研究.
- 样本包括2685名50岁以上的个人,通过神经测试和问卷评估认知状态.
- 隐性类分析 (LCA) 确定了风险概况;多项逻辑回归分析了与认知状态 (正常,MCI,SCI) 的关联.
主要成果:
- 确定了四种不同的潜伏特征:低风险,组合集群,不活动行为和心脏代谢风险.
- 综合集群概况 (心理健康不佳,体力活动低,高血压) 显示MCI (OR=3.11) 和SCI (OR=7.30) 的几率明显更高.
- 与低风险组相比,其他个人资料也显示了与轻度认知障碍 (MCI) 和严重认知障碍 (SCI) 的不同关联.
结论:
- 在欧洲老年人中发现了四种不同的认知障碍风险概况.
- 组合集群概况对MCI和SCI都有最重要的风险.
- 建议制定综合公共卫生战略,针对组合风险因素,特别是组合集群概况中的风险因素.
相关概念视频
Cognitive Development During Adulthood
768
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
768
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K


